Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165373 | SCV000216100 | uncertain significance | Hereditary cancer-predisposing syndrome | 2014-07-21 | criteria provided, single submitter | clinical testing | The c.530_532dupCCC variant located in coding exon 4 of the TP53 gene, results from a duplication of 3 nucleotides at positions 530 to 532 and the insertion of a proline residue at codon 178. The insertion of this proline will likely have a structurally destabilizing effect on the protein because it is located between C176 and H179; two residues necessary for binding the Zn+ molecule which stabilizes the p53 protein, however direct evidence is unavailable (Martin A et al. Hum. Mutat. 2002 Feb;19(2):149-64). Since supporting evidence is limited at this time, the clinical significance of c.530_532dupCCC remains unclear. |